RANDOLPH C. STEER, M.D., PH.D. - Corporate Board Profile

BIO-TECHNE Corp

Filing Date	Source Excerpt
2005-09-27	Randolph C. Steer, 55 Director Consultant to the 1990 M.D., Ph.D. pharmaceutical and biotechnology industries since 1989; Chairman (1999-2000) of Vicus.com, Inc.; Director of BioCryst Pharmaceuticals, Inc. The Audit Committee (whose members are Messrs. Herbert, O'Connell and Baumgartner and Dr. Steer) operates under a written charter established by the Company's Board of Directors. The Executive Compensation Committee (whose members are Dr. Steer and Messrs. Herbert, O'Connell and Baumgartner) determines compensation for executive officers of the Company.
2006-09-26	Randolph C. Steer, M.D., Ph.D. 56 Director Consultant to the 1990 pharmaceutical and biotechnology industries since 1989; Director of BioCryst Pharmaceuticals, Inc. The Company's Board of Directors has three standing Committees, the Audit Committee, the Executive Compensation Committee and the Nominations and Governance Committee. All members of all Committees are "independent" as such term is defined in applicable law and regulations of the Securities and Exchange Commission and Nasdaq. The Audit Committee (whose members are Messrs. Baumgartner, Herbert and O'Connell and Dr. Steer) operates under a written charter established by the Company's Board of Directors. The Executive Compensation Committee (whose members and Messrs. Herbert, O'Connell and Baumgartner and Dr. Steer) determines compensation for executive officers of the Company.
2007-09-26	Randolph C. Steer, 57 Director Consultant to the 1990 M.D., Ph.D. pharmaceutical and biotechnology industries since 1989; Director of BioCryst Pharmaceuticals, Inc.
2008-09-18	Randolph C. Steer, 58 Director Consultant to the 1990 M.D., Ph.D. pharmaceutical and biotechnology industries since 1989; Director of BioCryst Pharmaceuticals, Inc.
2009-09-22	Randolph C. Steer, 59 Director President and Chief 1990 M.D., Ph.D. Operating Officer of OrthoLogic Corp., a biotechnology company, since 2006. Consultant to the pharmaceutical and biotechnology industries from 1989 to 2006. Director of OrthoLogic Corp.
2010-09-17	Randolph C. Steer, M.D., Ph.D. 27,000 99,500 126,500
2011-09-16	Randolph C. Steer, M.D., Ph.D. Age: 61 Role: Director Committees: Audit Committee, Executive Compensation Committee Compensation: $108,500 Excerpt: "Dr. Steer, M.D., Ph.D. has served on the Company’s Board since 1990..." and "2011 Director Compensation: Randolph C. Steer, M.D., Ph.D., $108,500 total compensation."
2012-09-14	Randolph C. Steer, M.D., Ph.D. has served on the Company 27s Board since 1990. Dr. Steer received his undergraduate degree in physiology and Ph.D. in pathobiology from the University of Minnesota and his medical degree from the Mayo Medical School. Dr. Steer is currently an independent biotechnology consultant. He served as President and Chief Operating Officer of Capstone Therapeutics Corp. from April 2006 to October 2011. Dr. Steer was elected to the Mayo Clinic Board of Trustees in November 2011. In the past five years, Dr. Steer also served as a director of BioCryst Pharmaceuticals, Inc. and Vital Therapies, Inc. Dr. Steer was a consultant to the pharmaceutical and biotechnology industries from 1989 to 2006, where he advised companies in business development, medical marketing and regulatory and clinical affairs. His prior experience includes service as Associate Director of Medical Affairs at Marion Laboratories and as Medical Director at Ciba Consumer Pharmaceuticals. Among other attributes, skills and qualifications, the Board believes Dr. Steer is qualified to serve as a Director of the Company because his medical and scientific backgrounds and his knowledge of the pharmaceutical and biotechnology industries provide valuable strategic insight.
2013-09-20	Randolph C. Steer, M.D., Ph.D. has served on the Company 27s Board since 1990. Dr. Steer received his undergraduate degree in physiology and Ph.D. in pathobiology from the University of Minnesota and his medical degree from the Mayo Medical School. Dr. Steer is currently an independent biotechnology consultant. He served as President and Chief Operating Officer of Capstone Therapeutics Corp. from April 2006 to October 2011. Dr. Steer was elected to the Mayo Clinic Board of Trustees in November 2011. In the past five years, Dr. Steer also served as a director of BioCryst Pharmaceuticals, Inc. and Vital Therapies, Inc. Dr. Steer was a consultant to the pharmaceutical and biotechnology industries from 1989 to 2006, where he advised companies in business development, medical marketing and regulatory and clinical affairs. His prior experience includes service as Associate Director of Medical Affairs at Marion Laboratories and as Medical Director at Ciba Consumer Pharmaceuticals. Among other attributes, skills and qualifications, the Board believes Dr. Steer is qualified to serve as a Director of the Company because his medical and scientific backgrounds and his knowledge of the pharmaceutical and biotechnology industries provide valuable strategic insight.
2014-09-19	Randolph C. Steer, M.D., Ph.D. has served on the Companys Board since 1990. ... During fiscal 2014, the members of the Executive Compensation Committee were Dr. Steer (Chair) ... Randolph C. Steer, M.D., Ph.D. $217,640 total compensation.
2015-09-18	Randolph C. Steer, M.D., Ph.D., age 65, has served on the Company’s Board since 1990. ... Dr. Steer is currently an independent biotechnology consultant. ... The Board believes Dr. Steer is qualified to serve as a Director of the Company because his medical and scientific backgrounds and his knowledge of the pharmaceutical and biotechnology industries provide valuable strategic insight.
2016-09-13	Randolph C. Steer, M.D., Ph.D., age 66, has served on the Company’s Board since 1990. ... The Board currently has three standing Committees: the Audit Committee, the Executive Compensation Committee and the Nominations and Governance Committee. ... The membership of each standing committee during FY 2016 ... Randolph C. Steer, M.D., Ph.D.: Executive Compensation (Chair). ... Directors who are not employees of the Company were compensated for FY 2016 as follows: Randolph C. Steer, M.D., Ph.D. total $256,979.
2017-09-12	Dr. Steer is currently an independent biotechnology consultant... Director Compensation for FY 2017: Randolph C Steer total $267,986.